Abstract:Aims: Abnormalities in specific echocardiographic parameters and cardiac biomarkers have been reported among individuals with diabetes. However, a comprehensive characterization of diabetic cardiomyopathy (DbCM), a subclinical stage of myocardial abnormalities that precede the development of clinical heart failure (HF), is lacking. In this study, we developed and validated a machine learning-based clustering approach to identify the high-risk DbCM phenotype based on echocardiographic and cardiac biomarker parameters. Methods and results: Among individuals with diabetes from the Atherosclerosis Risk in Communities (ARIC) cohort who were free of cardiovascular disease and other potential aetiologies of cardiomyopathy (training, n = 1199), unsupervised hierarchical clustering was performed using echocardiographic parameters and cardiac biomarkers of neurohormonal stress and chronic myocardial injury (total 25 variables). The high-risk DbCM phenotype was identified based on the incidence of HF on follow-up. A deep neural network (DeepNN) classifier was developed to predict DbCM in the ARIC training cohort and validated in an external community-based cohort (Cardiovascular Health Study [CHS]; n = 802) and an electronic health record (EHR) cohort (n = 5071). Clustering identified three phenogroups in the derivation cohort. Phenogroup-3 (n = 324, 27% of the cohort) had significantly higher 5-year HF incidence than other phenogroups (12.1% vs. 4.6% [phenogroup 2] vs. 3.1% [phenogroup 1]) and was identified as the high-risk DbCM phenotype. The key echocardiographic predictors of high-risk DbCM phenotype were higher NT-proBNP levels, increased left ventricular mass and left atrial size, and worse diastolic function. In the CHS and University of Texas (UT) Southwestern EHR validation cohorts, the DeepNN classifier identified 16% and 29% of participants with DbCM, respectively. Participants with (vs. without) high-risk DbCM phenotype in the external validation cohorts had a significantly higher incidence of HF (hazard ratio [95% confidence interval] 1.61 [1.18-2.19] in CHS and 1.34 [1.08-1.65] in the UT Southwestern EHR cohort). Conclusion: Machine learning-based techniques may identify 16% to 29% of individuals with diabetes as having a high-risk DbCM phenotype who may benefit from more aggressive implementation of HF preventive strategies.

Deep learning imaging phenotype can classify metabolic syndrome and is predictive of cardiometabolic disorders

Auto-Segmentation Ultrasound-Based Radiomics Technology to Stratify Patient with Diabetic Kidney Disease: A Multi-Center Retrospective Study.

Deep Learning-Derived 12-Lead Electrocardiogram-Based Genotype Prediction for Hypertrophic Cardiomyopathy: a Pilot Study.

Development and validation of a machine learning-based approach to identify high-risk diabetic cardiomyopathy phenotype

Disease phenotyping using deep learning: A diabetes case study

Deep Learning-Enabled Assessment of Left Heart Structure and Function Predicts Cardiovascular Outcomes

Deep Learning–Based Assessment of Built Environment From Satellite Images and Cardiometabolic Disease Prevalence

Deep‐Learning‐Based Disease Classification in Patients Undergoing Cine Cardiac MRI

A comprehensive multi-task deep learning approach for predicting metabolic syndrome with genetic, nutritional, and clinical data

A Deep Learning System for Detecting Cardiomegaly Disease Based on CXR Image

Identification of High-Risk Imaging Features in Hypertrophic Cardiomyopathy using Electrocardiography: A Deep-Learning Approach

Identification of Hypertrophic Cardiomyopathy on Electrocardiographic Images with Deep Learning

Metabolic phenotyping with computed tomography deep learning for metabolic syndrome, osteoporosis and sarcopenia predicts mortality in adults

Deep Learning Discovery of Demographic Biomarkers in Echocardiography

Deep Learning–Based Automated Imaging Classification of ADPKD

Early Classification of Emphysema in CT Scans Using Deep Learning

Deep learning algorithm to improve hypertrophic cardiomyopathy mutation prediction using cardiac cine images

A Primer for Utilizing Deep Learning and Abdominal MRI Imaging Features to Monitor Autosomal Dominant Polycystic Kidney Disease Progression

Deep learning from latent spatiotemporal information of the heart: Identifying advanced bioimaging markers from echocardiograms

Abstract 17610: A Novel Approach Using Deep Neural Networks on Clinical Cardiac MRIs Can Identify Patients With Clonal Hematopoiesis of Indeterminate Potential With High Accuracy

Detecting Underdiagnosed Medical Conditions with Deep Learning-Based Opportunistic CT Imaging